Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kavanagh

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 9, 2018
Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancerChad G Rusthoven, Bernard L Jones, Brian D Kavanagh
Frontiers of Radiation Therapy and Oncology|July 21, 2007
Lung cancer: a model for implementing stereotactic body radiation therapy into practiceRobert Timmerman, Ramzi Abdulrahman, Brian D Kavanagh, et al.
Journal of Medical Imaging and Radiation Oncology|July 1, 2014
Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiformeKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
Oncology (Williston Park, N.Y.)|December 22, 2004
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimizationDanny Y Song, Brian D Kavanagh, Stanley H Benedict, et al.
Journal of Neurosurgery|August 8, 2015
Inception of a national multidisciplinary registry for stereotactic radiosurgeryJason P Sheehan, Brian D Kavanagh, Anthony Asher, et al.
Clinical Lung Cancer|May 27, 2008
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trialsKyle E Rusthoven, Thomas W Flaig, David Raben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2010
Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuliLian Zhang, Brian D Kavanagh, Andrew M Thorburn, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2013
The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact?Iris C Gibbs, Daphne Haas-Kogan, Stephanie Terezakis, et al.
Practical Radiation Oncology|July 5, 2017
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysisWilliam A Stokes, Brian D Kavanagh, David Raben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?Chad G Rusthoven, David A Palma, Suresh Senan, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Thoracic and Cardiovascular Surgery|February 9, 2018
Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancerChad G Rusthoven, Bernard L Jones, Brian D Kavanagh
Frontiers of Radiation Therapy and Oncology|July 21, 2007
Lung cancer: a model for implementing stereotactic body radiation therapy into practiceRobert Timmerman, Ramzi Abdulrahman, Brian D Kavanagh, et al.
Journal of Medical Imaging and Radiation Oncology|July 1, 2014
Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiformeKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
Oncology (Williston Park, N.Y.)|December 22, 2004
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimizationDanny Y Song, Brian D Kavanagh, Stanley H Benedict, et al.
Journal of Neurosurgery|August 8, 2015
Inception of a national multidisciplinary registry for stereotactic radiosurgeryJason P Sheehan, Brian D Kavanagh, Anthony Asher, et al.
Clinical Lung Cancer|May 27, 2008
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trialsKyle E Rusthoven, Thomas W Flaig, David Raben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2010
Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuliLian Zhang, Brian D Kavanagh, Andrew M Thorburn, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2013
The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact?Iris C Gibbs, Daphne Haas-Kogan, Stephanie Terezakis, et al.
Practical Radiation Oncology|July 5, 2017
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysisWilliam A Stokes, Brian D Kavanagh, David Raben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?Chad G Rusthoven, David A Palma, Suresh Senan, et al.
Pageof 15